glp-1 agonist eli lilly FDA approves Foundayo, an oral alternative to Wegovy and Ozempic Why Eli Lilly is suddenly

Ronner P, Naumann CM, Friel E

medRxiv 26(9):39063913 Wharton S et al (2019) The effectiveness and safety of pharmaceuticals to manage excess weight post-bariatric surgery: a systematic literature review

And with addiction, more than any other disease, the number of deaths averted captures just a piece of the devastating cascade of downstream consequences that tear apart families, communities, and entire countries

Gastrointestinal Effects The most frequent adverse effects of GLP-1RAs are gastrointestinal, including nausea, vomiting, diarrhoea and a sensation of early satiety

Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinsons disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial